News from kempharm, inc. A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 07, 2013, 08:10 ET

KemPharm, Inc. Receives Additional Notice of Allowance for Novel Prodrugs of Hydrocodone

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...

Jul 15, 2013, 08:10 ET

KemPharm, Inc. Appoints Gordon K. "Rusty" Johnson as Chief Operating Officer and Chief Financial Officer

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...

Jun 11, 2013, 08:33 ET

KemPharm, Inc. Receives Patent from the USPTO for Novel Pain Drug Candidate, KP201

KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...

Jun 04, 2013, 08:33 ET

KemPharm's KP201 Featured at the International Conference on Opioids

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...

Apr 16, 2013, 08:48 ET

KemPharm Advances KP201 Clinical and Commercial Program with Completion of Tablet Registration Activities

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...

Apr 03, 2013, 09:17 ET

KemPharm, Inc. Receives Notice of Allowance for Novel Pain Drug Candidate, KP201

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...

Feb 14, 2013, 10:33 ET

KemPharm Supports Recent FDA Recommendations for Hydrocodone-Containing Compounds and Abuse-Deterrent Opioids

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...

Jan 07, 2013, 10:10 ET

KemPharm, Inc Receives USAN Approval for Nonproprietary Name of Novel Pain Drug Candidate, KP201

KemPharm, Inc, a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced...

Jan 02, 2013, 15:49 ET

KemPharm, Inc. to Present at Biotech Showcase™ 2013

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...

May 24, 2011, 08:33 ET

KemPharm, Inc. Announces Positive Results from Phase 1 Trial of KP201 for Pain

KemPharm, Inc. today announced positive results from a Phase 1 clinical trial of its most advanced opioid-based drug candidate, KP201, a novel...

Apr 25, 2011, 08:33 ET

KemPharm, Inc. Announces Plans to Launch KP106 as First Oral Film Dosage Form for ADHD

KemPharm, Inc. today announced that KP106, its clinical candidate for Attention Deficit/Hyperactivity Disorder (ADHD), will be formulated and...

Aug 25, 2010, 06:00 ET

KemPharm, Inc. Receives Notice of Issuance from USPTO on Second Patent Protecting Company's ADHD Prodrug Technology

KemPharm, Inc. announced today that it has received a Notice of Issuance from the United States Patent and Trademark Office (USPTO) for its patent...

Aug 16, 2010, 06:00 ET
KemPharm logo.  (PRNewsFoto/KemPharm, Inc.)

KemPharm, Inc. Receives Notice of Issuance From USPTO on Patent Protecting Company's ADHD Prodrug Technology

KemPharm, Inc. announced today that it has received a Notice of Issuance from the United States Patent and Trademark Office (USPTO) for its patent...

Jun 23, 2010, 06:00 ET
KemPharm logo.  (PRNewsFoto/KemPharm, Inc.)

KemPharm, Inc. Appoints Todd Johnson, Ph.D. as Chief Commercial Officer

KemPharm, Inc. announced today that Todd J. Johnson, Ph.D., a current member of the company's board of directors, has recently joined the company...

May 18, 2010, 06:00 ET
A F KEMPHARM LOGO KEMPHARM LOGO

KemPharm logo. (PRNewsFoto/KemPharm, Inc.)[TK]
 NORTH LIBERTY, IA UNITED STATES
 05/17/2010

KemPharm, Inc. Announces Entering Into an Exclusive Supply Agreement With Johnson Matthey Inc. for KP201

KemPharm, Inc. today announced that it has entered into an exclusive Supply Agreement with Johnson Matthey Inc., for the manufacture of the active...